Tempest Therapeutics, Inc.
TPST
$6.90
$0.294.39%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 21.51M | 30.27M | 22.12M | 31.12M | 32.33M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 448.00K | 642.00K | 811.00K | 272.00K | 585.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 474.00K | 564.00K | 625.00K | 152.00K | 586.00K |
Total Current Assets | 22.43M | 31.47M | 23.55M | 31.55M | 33.50M |
|
|||||
Total Current Assets | 22.43M | 31.47M | 23.55M | 31.55M | 33.50M |
Net Property, Plant & Equipment | 9.19M | 9.53M | 9.84M | 10.17M | 10.43M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 538.00K | 485.00K | 448.00K | 448.00K | 448.00K |
Total Assets | 32.16M | 41.49M | 33.84M | 42.17M | 44.38M |
|
|||||
Total Accounts Payable | 2.19M | 2.45M | 1.70M | 1.36M | 1.05M |
Total Accrued Expenses | 5.74M | 4.55M | 2.94M | 3.62M | 2.32M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 5.25M | 7.22M | 9.33M | 9.58M | 7.32M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 13.18M | 14.22M | 13.97M | 14.56M | 10.69M |
|
|||||
Total Current Liabilities | 13.18M | 14.22M | 13.97M | 14.56M | 10.69M |
Long-Term Debt | -- | -- | -- | 2.01M | 4.14M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 7.85M | 8.14M | 8.41M | 8.66M | 8.92M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 21.03M | 22.36M | 22.38M | 25.23M | 23.75M |
|
|||||
Common Stock & APIC | 229.10M | 226.23M | 204.75M | 199.68M | 193.80M |
Retained Earnings | -217.97M | -207.11M | -193.29M | -182.74M | -173.17M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 11.13M | 19.13M | 11.46M | 16.94M | 20.63M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.13M | 19.13M | 11.46M | 16.94M | 20.63M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 11.13M | 19.13M | 11.46M | 16.94M | 20.63M |
|